Top Pharmaceuticals Startups in 2026

Dyania’s mission is to deploy their medically specialized and proprietary Synapsis AI to automate manual chart review, one of the most inefficient and time-consuming processes in modern healthcare, thereby empowering clinicians to deliver optimal care, precisely when patients need it. Dyania’s system is being used at large healthcare systems to unlock enterprise-wide clinical trial pre-screening, run automated chart review for observational studies, and automate complex registry reporting, dramatically reducing manual workloads and ensuring more accurate and timely patient care.

Basetwo provides a no code AI platform that helps manufacturing engineers troubleshoot and optimize their production processes to increase efficiency and reduce waste. Manufacturing engineers can use the Basetwo platform to rapidly ingest, merge and transform large datasets in order to build actionable digital twins of their plant. Using Basetwo's library of digital twins, engineers can improve their understanding of their plant performance, and run real-time scenario analyses to improve yield, product quality and efficiency of their plant.

Savara is an inhalation drug development company. Our lead product addresses an unmet clinical need in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis (CF) and in other high risk patient populations. MRSA is a growing problem, with a 6 year reduction in life expectancy for infected CF patients and no suitable treatment. The product is in preparation for its first human clinical trial.

Simon-Kucher, they have over 30 years of experience in creating top- and bottom-line growth strategies that deliver measurable results. A project with us increases their clients’ profitability by 100 to 500 basis points on average.They are especially renowned for their pricing experience. This is where they started, and this is where their core competence remains. Or, as acclaimed Northwestern University marketing professor Philip Kotler says, “No one knows more about pricing than Simon-Kucher.” Their solutions are made to last. That is easily said, but not so easily done in today’s dynamic business environment. The world has never been so dynamic, with digitalization unhinging established revenue models and urging everyone to rethink the way they market, price and sell products and services. At Simon-Kucher, they are ahead of these developments, and their solutions prepare their clients for the digital era.

Safetraces, Inc. lets you trace food from fork-to-farm - quickly and safely.

We are a life sciences consultancy that wishes to acquire a brand new factory previously owned by a major pharmaceutical company to make cancer drugs for clinical studies. This business would operate as a contract manufacturing operation (CMO), specializing in cytotoxic or highly potent compounds. Oncology is a lucrative part of the life sciences industry, and has more growth potential then the rest of the categories in pharmaceuticals. The funding is strictly for the assets, we will bring the sweat equity to get the facility commissioned, qualified and validated to Food and Drug Administration Standards as well as well as European Medicines Agency Standards.

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from living organisms. By developing a comprehensive database of chemical biodiversity, Enveda aims to accelerate the discovery of new medicines.

The Stellix Group of companies share a common mission of providing transformative solutions at the intersection of science and technology that enable our customers to deliver a healthier and more sustainable future. Stellix teams (NECI, ZAETHER, KYNOTA, and Stellix Global Services) are focused on helping life sciences and industry manufacturers build, connect, and transform operations and IT to make real progress in breakthroughs for therapeutics, food, energy, and more.